We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » BD Expands into Posttreatment Cancer Monitoring With Cytognos Buyout
BD Expands into Posttreatment Cancer Monitoring With Cytognos Buyout
Becton Dickinson (BD) has completed its purchase of Cytognos, a privately held Spanish company that specializes in flow cytometry products for blood cancers.